Furthermore, Luo et al. reported that miR-124-3p suppressed the aggressiveness of glioma by targeting Fos-related antigen-2, suggesting potential applications of this miRNA in the treatment of this disease 21. The gene discussed is FOSL2; the disease is central nervous system cancer.